-
-
-
-
-
-
-
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
-
-
-
-
-
-
-
Forte Biosciences (FBRX) Declares Dividend Distribution of One Right per One Common Share
-
-
-
-
-
-
-
Forte Biosciences, Inc. Announces Closing of Merger With Tocagen
1,185,380 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

